The narrow defensible claim is that Ipamorelin was more selective than GHRP-6 and GHRP-2 at the somatotroph in animals
Additionally, long-acting liraglutide and ultralong-acting semaglutide can mitigate the risk of adverse cardiovascular events in T2DM patients, whereas exenatide has no substantial effect on the incidence of adverse cardiovascular events (60)
Early data showed promising efficacy in non-diabetic obese patients comparable to Lillys Orforglipron with a downward trend in weight loss, although the effect size was less than that of Orforglipron in diabetes subgroup
(8) A B W Tavares, E Micmacher, S Biesek, R Assumpo, et al (2013) Effects of Growth Hormone Administration on Muscle Strength in Men over 50 Years Old International Journal of Endocrinology, 2013 Dec 8, Volume 2013, Page 942030
Because it has not reported, the answer is unpublished not reassuring, not alarming, simply unknown
Both injections carry the normal risks of any injectable, but the bigger concern with unlicensed products is that complications are harder to predict and harder to treat